|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
528
|
Wed, 8/5/09, 2:00 PM - 3:50 PM | CC-201 |
| Issues in Multi-Regional Trials, Medical Device Trials, and Sample Size - Contributed - Papers | ||
|
Biopharmaceutical Section |
||
| Chair(s): Kyung Sook Kim, FDA | ||
| 2:05 PM |
A New Approach to Model Region Treatment Effects in Clinical Trials —  Hua Guo, Merck Research Laboratories
|
|
| 2:20 PM |
Power and Multiplicity Assessment for a Composite Endpoint and Its Components in Multi-Regional Clinical Trials — Hongwei Wang, Merck & Co., Inc.; Weili He, Merck & Co., Inc.; Liang Chen, Merck & Co., Inc.
|
|
| 2:35 PM |
Determination of Sample Size in Multi-Regional Clinical Trials — Feng-shou Ko, National Health Research Institutes; Hsiao-hui Tsou, National Health Research Institutes; Chin-fu Hsiao, National Health Research Institutes
|
|
| 2:50 PM |
An Algorithm for Selecting Cases to Evaluate a Digital Mammography System — David C. Hoaglin, Abt Bio-Pharma Solutions, Inc.; Lynn Fletcher-Heath, Carestream Health, Inc.
|
|
| 3:05 PM |
Adjusting for Nonignorable and Partially Ignorable Verification Bias in Estimating ROC Curve and Its Area — Danping Liu, University of Washington; Xiao-Hua (Andrew) Zhou, University of Washington
|
|
| 3:20 PM |
Ceiling and Regression Effects on Clinical Endpoints in Medical Device Studies — Daniel P. Reyner, Zimmer Holdings, Inc
|
|
| 3:35 PM |
Sample Size Determination and Interpretation of Safety Findings in Clinical Studies with an MTD Expansion Cohort — Guohui Liu, Millennium Pharmaceuticals; Noe Dennis, Millennium Pharmaceuticals
|
|
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |